![]() |
20th November 2008 @ 1:39pm |
| Subscribe | Instructions To Authors | Advertising/Supplements | Contact Us | Help |
|
Volume 15, Number 2, March-April 2008Effect of ivabradine, a novel anti-anginal agent, on heart rate and symptom control: a first experience in a clinical ‘real-world’ setting An elevated heart rate may be a primary determinant of myocardial ischaemia by altering the balance of oxygen demand and coronary perfusion. Given that there is considerable evidence showing survival is inversely related to heart rate, lowering heart rate would be expected to be an important tool in the management of angina.1-3 Theoretically it may also be beneficial in the prevention of myocardial infarction as the haemodynamic stresses placed upon the myocardium by a high heart rate are associated with coronary plaque rupture Br J Cardiol 2008;15:106-109. View full PDF article (open in new window) |